Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Ventricular arrhythmias in mouse models of diabetic kidney disease

Open access

Abstract

Chronic kidney disease (CKD) affects more than 20 million people in the US, and it is associated with a significantly increased risk of sudden cardiac death (SCD). Despite the significance, the mechanistic relationship between SCD and CKD is not clear and there are few effective therapies. Using optical mapping techniques, we tested the hypothesis that mouse models of progressive diabetic kidney disease (DKD) exhibit enhanced ventricular arrhythmia incidence and underlying arrhythmia substrates. Compared to wild-type mice, both Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose streptozotocin (HFD + STZ) mouse models of DKD experienced sudden death and greater arrhythmia inducibility, which was more common with isoproterenol than programmed electrical stimulation. 2KO mice demonstrated slowed conduction velocity, prolonged action potential duration (APD), and myocardial fibrosis; both 2KO and HFD + STZ mice exhibited arrhythmias and calcium dysregulation with isoproterenol challenge. Finally, circulating concentrations of the uremic toxin asymmetric dimethylarginine (ADMA) were elevated in 2KO mice. Incubation of human cardiac myocytes with ADMA prolonged APD, as also observed in 2KO mice hearts ex vivo. The present study elucidates an arrhythmia-associated mechanism of sudden death associated with DKD, which may lead to more effective treatments in the vulnerable DKD patient population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-99891-9

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Kaplan–Meier survival curves for in wild-type (N = 8), Leprdb/db eNOS−/− (2KO, N = 11), and high fat diet plus low dose STZ-treated (HFD + STZ, N = 20) mice. *P < 0.05 by χ2 and Mantel-Cox log-rank test compared to other groups.
Figure 1 Kaplan–Meier survival curves for in wild-type (N = 8), Leprdb/db eNOS−/− (2KO, N = 11), and high fat diet plus low dose STZ-treated (HFD + STZ, N = 20) mice. *P < 0.05 by χ2 and Mantel-Cox log-rank test compared to other groups.CC BY · PubMed Central
Figure 2 Arrhythmias induced by programmed electrical stimulation (A), and by isoproterenol challenge (B) in Lepr db/db eNOS −/− (2KO) mice (left) and HFD + STZ mice (right). ECG and action potential (AP) traces were recorded from Langendorff perfused hearts. AP action potential, ECG electrocardiogram, S1 baseline pacing, S2 premature stimulus.
Figure 2 Arrhythmias induced by programmed electrical stimulation (A), and by isoproterenol challenge (B) in Lepr db/db eNOS −/− (2KO) mice (left) and HFD + STZ mice (right). ECG and action potential (AP) traces were recorded from Langendorff perfused hearts. AP action potential, ECG electrocardiogram, S1 baseline pacing, S2 premature stimulus.CC BY · PubMed Central
Figure 3 Optical mapping of action potentials from the anterior epicardial surface of Langendorff perfused hearts. (A) Activation maps showing impulse propagation in wild type (WT), Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. Stimulation was performed from the center of the mapping field of view at a cycle length of 110 ms. Arrows shown in WT example depict local conduction velocity vectors that were measured in the fast (longitudinal) and slow (transverse) direction of propagation. (B) Summary data for conduction velocity in the longitudinal (CVL) and transverse (CVT) directions, as well as CVL/CVT (anisotropy ratio) in WT (n = 10), 2KO (n = 8) and HFD + STZ treated mice (n = 8). Data are mean ± SEM. P values were generated by Fisher’s least significant difference test for multiple comparisons.
Figure 3 Optical mapping of action potentials from the anterior epicardial surface of Langendorff perfused hearts. (A) Activation maps showing impulse propagation in wild type (WT), Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. Stimulation was performed from the center of the mapping field of view at a cycle length of 110 ms. Arrows shown in WT example depict local conduction velocity vectors that were measured in the fast (longitudinal) and slow (transverse) direction of propagation. (B) Summary data for conduction velocity in the longitudinal (CVL) and transverse (CVT) directions, as well as CVL/CVT (anisotropy ratio) in WT (n = 10), 2KO (n = 8) and HFD + STZ treated mice (n = 8). Data are mean ± SEM. P values were generated by Fisher’s least significant difference test for multiple comparisons.CC BY · PubMed Central
Figure 4 Histology (Masson’s trichrome stain) in wild type (WT), Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. Low magnification view from all three models (A–C) indicate the absence of large areas of scar typically associated with myocardial infarction. Diffuse fibrosis (area within black dashed line) was only observed in 2KO mice (E,H). Each image is from a different tissue sample.
Figure 4 Histology (Masson’s trichrome stain) in wild type (WT), Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. Low magnification view from all three models (A–C) indicate the absence of large areas of scar typically associated with myocardial infarction. Diffuse fibrosis (area within black dashed line) was only observed in 2KO mice (E,H). Each image is from a different tissue sample.CC BY · PubMed Central
Figure 5 Action potential duration (APD) and APD dispersion in wild type (WT), Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. (A) Action potential traces show APD at 90% repolarization. Summary data for APD (B) and APD dispersion (C). Data are mean ± SEM. P values were generated by Fisher’s least significant difference test for multiple comparisons.
Figure 5 Action potential duration (APD) and APD dispersion in wild type (WT), Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. (A) Action potential traces show APD at 90% repolarization. Summary data for APD (B) and APD dispersion (C). Data are mean ± SEM. P values were generated by Fisher’s least significant difference test for multiple comparisons.CC BY · PubMed Central
Figure 6 Examples of arrhythmias induced by isoproterenol (Iso) challenge and spontaneous calcium release (SCR) in Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. (A) Calcium transients with evidence of spontaneous calcium release (SCR, arrow) following the termination of rapid pacing (S) only in the presence of Iso (top trace). (B) Dual voltage-calcium optical mapping results. Activation maps were determined from action potentials measured simultaneously with calcium transients. The site of arrhythmia initiation (VT first beat, left panel B) is associated with the location of SCR (site a), rather than the absence of SCR (site b) following rapid pacing (s), as depicted in the calcium transient traces (right, Panel B). The activation map corresponding to sinus rhythm is shown in the right panel as a reference. Note the difference in time scale between the two maps.
Figure 6 Examples of arrhythmias induced by isoproterenol (Iso) challenge and spontaneous calcium release (SCR) in Leprdb/db eNOS−/− (2KO) and high fat diet plus low dose STZ-treated (HFD + STZ) mice. (A) Calcium transients with evidence of spontaneous calcium release (SCR, arrow) following the termination of rapid pacing (S) only in the presence of Iso (top trace). (B) Dual voltage-calcium optical mapping results. Activation maps were determined from action potentials measured simultaneously with calcium transients. The site of arrhythmia initiation (VT first beat, left panel B) is associated with the location of SCR (site a), rather than the absence of SCR (site b) following rapid pacing (s), as depicted in the calcium transient traces (right, Panel B). The activation map corresponding to sinus rhythm is shown in the right panel as a reference. Note the difference in time scale between the two maps.CC BY · PubMed Central
Figure 7 Effects of TMAO and ADMA on impulse conduction in human cardiac myocyte monolayers. (A) Activation maps showing impulse propagation in response to TMAO (100 µM), ADMA (10 µM) or DMSO vehicle only (control, CNTL). Stimulus symbol (square wave) is the site of point infrared stimulation. (B) Summary data for conduction velocity in the longitudinal (CVL) and transverse (CVT) directions. Effects of TMAO and ADMA on action potential duration (APD) in human cardiac myocyte monolayers (C). Single site action potentials (left) in the presence of TMAO (100 µM), ADMA (10 µM) or DMSO vehicle only (control). Summary data (right) for APD. Data are mean ± SEM. P values were generated by Fisher’s least significant difference test for multiple comparisons.
Figure 7 Effects of TMAO and ADMA on impulse conduction in human cardiac myocyte monolayers. (A) Activation maps showing impulse propagation in response to TMAO (100 µM), ADMA (10 µM) or DMSO vehicle only (control, CNTL). Stimulus symbol (square wave) is the site of point infrared stimulation. (B) Summary data for conduction velocity in the longitudinal (CVL) and transverse (CVT) directions. Effects of TMAO and ADMA on action potential duration (APD) in human cardiac myocyte monolayers (C). Single site action potentials (left) in the presence of TMAO (100 µM), ADMA (10 µM) or DMSO vehicle only (control). Summary data (right) for APD. Data are mean ± SEM. P values were generated by Fisher’s least significant difference test for multiple comparisons.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 1

  1. Chou, C. C. et al. Roles of impaired intracellular calcium cycling in arrhythmogenicity of diabetic mouse model. Pacing Clin. Electrophysiol. (PACE) 40(10), 1087–1095 (2017). · DOI

Cited by

See all 8

Metadata

Authors
Laurita, K. R., Khan, S., McMahon, T., Dennis, A. T., Li, V., Gaivin, R., Sapa, H., Fu, J.-D., & Schelling, J. R.
Affiliations
  • MetroHealth (US)
  • University Hospitals of Cleveland (US)
Corresponding author
Laurita, Kenneth R.
Venue
Scientific Reports
Published
2021-10-18
Volume
11
Issue
1
Pages
20570-20570
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3206494527
Cited by
8
References
77
Citations by year
2025: 3 · 2024: 1 · 2023: 2 · 2022: 2
FWCI
0.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
NIH (HL123012, HL139006, DK106965)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
diabetic nephropathy, ventricular arrhythmias, sudden cardiac death, chronic kidney disease, arrhythmogenic substrate, myocardial fibrosis, conduction velocity, action potential duration, calcium dysregulation, asymmetric dimethylarginine, uremic toxins, cardiomyocytes, optical mapping
MeSH terms
Action Potentials, Animals, Arrhythmias, Cardiac, Diabetes Mellitus, Diabetic Nephropathies, Disease Models, Animal, Heart Rate, Male, Mice, Inbred C57BL, Tachycardia, Ventricular, Mice, Knockout, Myocytes, Cardiac, Diabetes Complications, Mice, Voltage-Sensitive Dye Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ventricular arrhythmias in mouse models of diabetic kidney disease. https://app.cochat.ai/papers/10.1038/s41598-021-99891-9
The paper
Laurita, K. R., Khan, S., McMahon, T., Dennis, A. T., Li, V., Gaivin, R., Sapa, H., Fu, J.-D., & Schelling, J. R. (2021). Ventricular arrhythmias in mouse models of diabetic kidney disease. Scientific Reports. https://doi.org/10.1038/s41598-021-99891-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.